I may not know what I am talking about with Bayer but my thoughts are that Bayer were interested in long length carbon fibres and high quality nanotubes suitable for medical use whereas EDE is interested in large volume short fibres suitable for large scale industrial use. Am I right or wrong?
eg.
Carbon nanotubes in biology and medicine: In vitro and in vivo detection, imaging and drug delivery
Ann: EdenCrete Shotcrete Applications Expanding in Colorado, page-58
-
- There are more pages in this discussion • 139 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EDE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.216M | |||
| Open | High | Low | Value | Volume |
| 0.2¢ | 0.2¢ | 0.2¢ | $1K | 500K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 60 | 137233047 | 0.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.2¢ | 13502282 | 13 |
View Market Depth
| Last trade - 10.02am 18/11/2024 (20 minute delay) ? |
| EDE (ASX) Chart |
